CD137 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD137 monoclonal antibodies for research focused on understanding immune system regulation. CD137 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD137, also known as 4-1BB, is a co-stimulatory molecule that plays a critical role in T cell activation and survival, making it essential for effective immune responses. CD137 influences immune cell proliferation and differentiation, particularly in immune responses against cancer and autoimmune conditions. Understanding CD137 function continues to be crucial for developing new immunotherapies and advancing our knowledge of immune regulation. CD137 research has revealed significant insights into T cell biology and immune system modulation. Ongoing studies of CD137 signaling pathways have enhanced our understanding of immune cell communication and regulation. CD137 monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance immunology research and contribute to the development of new therapeutic strategies.